Private Advisor Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.45M | Buy |
111,949
+3,531
| +3% | +$172K | 0.03% | 549 |
|
|
2025
Q1 | $3.69M | Buy |
108,418
+23,382
| +27% | +$796K | 0.02% | 641 |
|
|
2024
Q4 | $3.35M | Buy |
85,036
+13,289
| +19% | +$523K | 0.02% | 666 |
|
|
2024
Q3 | $3.37M | Sell |
71,747
-5,880
| -8% | -$276K | 0.02% | 656 |
|
|
2024
Q2 | $4.19M | Buy |
77,627
+64,076
| +473% | +$3.46M | 0.03% | 550 |
|
|
2024
Q1 | $923K | Buy |
13,551
+4,625
| +52% | +$315K | 0.01% | 1191 |
|
|
2023
Q4 | $559K | Buy |
8,926
+3,272
| +58% | +$205K | ﹤0.01% | 1392 |
|
|
2023
Q3 | $254K | Buy |
5,654
+618
| +12% | +$27.8K | ﹤0.01% | 1727 |
|
|
2023
Q2 | $283K | Buy |
5,036
+59
| +1% | +$3.31K | ﹤0.01% | 1665 |
|
|
2023
Q1 | $225K | Buy |
+4,977
| New | +$225K | ﹤0.01% | 1728 |
|
|
2022
Q4 | – | Sell |
-6,235
| Closed | -$407K | – | 1719 |
|
|
2022
Q3 | $407K | Buy |
6,235
+151
| +2% | +$9.86K | ﹤0.01% | 1336 |
|
|
2022
Q2 | $370K | Sell |
6,084
-358
| -6% | -$21.8K | ﹤0.01% | 1544 |
|
|
2022
Q1 | $404K | Sell |
6,442
-5,015
| -44% | -$315K | ﹤0.01% | 1522 |
|
|
2021
Q4 | $868K | Sell |
11,457
-1,485
| -11% | -$113K | 0.01% | 1188 |
|
|
2021
Q3 | $1.45M | Buy |
12,942
+3,083
| +31% | +$345K | 0.01% | 1032 |
|
|
2021
Q2 | $1.6M | Sell |
9,859
-545
| -5% | -$88.2K | 0.01% | 842 |
|
|
2021
Q1 | $1.27M | Buy |
10,404
+2,572
| +33% | +$313K | 0.01% | 897 |
|
|
2020
Q4 | $1.2M | Buy |
7,832
+3,346
| +75% | +$512K | 0.01% | 828 |
|
|
2020
Q3 | $375K | Sell |
4,486
-721
| -14% | -$60.3K | ﹤0.01% | 1169 |
|
|
2020
Q2 | $383K | Buy |
5,207
+340
| +7% | +$25K | 0.01% | 1115 |
|
|
2020
Q1 | $206K | Sell |
4,867
-2,832
| -37% | -$120K | ﹤0.01% | 1218 |
|
|
2019
Q4 | $469K | Buy |
+7,699
| New | +$469K | 0.01% | 1068 |
|
|
2019
Q3 | – | Sell |
-4,352
| Closed | -$205K | – | 1663 |
|
|
2019
Q2 | $205K | Buy |
+4,352
| New | +$205K | ﹤0.01% | 1501 |
|
|
2018
Q4 | – | Sell |
-8,260
| Closed | -$366K | – | 1395 |
|
|
2018
Q3 | $366K | Buy |
8,260
+4,485
| +119% | +$199K | 0.01% | 1131 |
|
|
2018
Q2 | $227K | Buy |
+3,775
| New | +$227K | ﹤0.01% | 1126 |
|